Expression of extracellular matrix molecules in brain metastasis

Journal of Surgical Oncology

Volumn 100, Issue 1, 2009, Pages 65-68

  Yoshida, Seiichi ^a   Takahashi, Hideaki ^a  

^a NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Brain metastasis; CD44; EGFR; MMP7; MT1 MMP

Indexed keywords

EPIDERMAL GROWTH FACTOR; HERMES ANTIGEN; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; CD44 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MMP14 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BRAIN TUMOR; CHEMISTRY; EXTRACELLULAR MATRIX; GENETICS; IMMUNOHISTOCHEMISTRY; METASTASIS; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ANTIGENS, CD44; BRAIN NEOPLASMS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 67649392519     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21296     Document Type: Article

References (29)

1. Albini A, Iwamoto Y, Kleinman HK, et al.: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-3245. (Pubitemid 17082655)
2. Cosman D: A family of ligands for the TNF receptor superfamily. Stem Cells 1994;12:440-455. (Pubitemid 24278224)
3. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-336. (Pubitemid 121001258)
4. McKenna GJ, Chen Y, Smith RM, et al.: A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am J Surg 2002;183:588-594. (Pubitemid 34603436)
5. O-Charoenrat P, Rhys-Evans PH, Eccles SA: Expression of matrixmetalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2000;127:813-820.
6. Vihinen P, Nikkola J, Vlaykova T, et al.: Prognostic value of beta1 integrin expression in metastatic melanoma. Melanoma Res 2000;10:243-251. (Pubitemid 30767925)
7. Nakada M, Kita D, Futami K, et al.: Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. J Neurosurg 2001;94:464-473. (Pubitemid 32786027)
8. Ge L, Resnick NM, Ernst LK, et al.: Gene therapeutic approaches to primary and metastatic brain tumors: II. Ribozyme-mediated suppression of CD44 expression. J Neurooncol 1995;26:251-257. (Pubitemid 26017814)
9. Hamasuna R, Kataoka H, Moriyama T, et al.: Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying upregulation of membrane type-1 MMP. Int J Cancer 1999;82:274-281. (Pubitemid 29293788)
10. Kajita M, Itoh Y, Chiba T, et al.: Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001;153:893-904. (Pubitemid 34289231)
11. Lampert K, Machein U, Machein MR, et al.: Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 1998;153:429-437. (Pubitemid 28373654)
12. Liotta LA: Tumor invasion and metastasis: Role of the extracellular matrix. Cancer Res 1991;51:5054-5059.
13. Och W, Mariak Z, Smolka M, et al.: Epidermal growth factor expression in brain neoplasms. Neurol Neurochir Pol 2000;34:1165-1172.
14. Ranuncolo SM, Ladeda V, Specterman S, et al.: CD44 expression in human gliomas. J Surg Oncol 2002;79:30-35. (Pubitemid 34049541)
15. Takino T, Sato H, Shinagawa A, et al.: Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library: MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995;270:23013-23020.
16. Kamoto I, Tsuiki H, Kenyon LC, et al.: Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol 2002;160:441-447. (Pubitemid 34160321)
17. Amar AP, DeArmond SJ, Spencer DR, et al.: Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion. J Neurooncol 1994;20:1-15. (Pubitemid 24299470)
18. Friedlander DR, Zagzag D, Shiff B, et al.: Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves ν and β1 integrins. Cancer Res 1996;56:1939-1947. (Pubitemid 26118235)
19. Jalinoja J, Herva R, Korpela M, et al.: Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms. J Neurooncol 2000;46:81-90. (Pubitemid 30352615)
20. Arai T, Ichimura K, Hirakawa K, et al.: DNA amplifications and elevated expression of proto-oncogene in addition to altered DNA ploidy in metastatic brain tumors. Clin Exp Metastasis 1994;12:267-275. (Pubitemid 24257064)
21. Theret N, Musso O, Turlin B, et al.: Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 2001;34:82-88. (Pubitemid 32591486)
22. Torp SH, Helseth E, Ryan L, et al.: Expression of the epidermal growth factor receptor gene in human brain metastases. Acta Pathol Microbiol Immunol Scand 1992;100:713-719.
23. Wild-Bode C, Weller M, Wick W: Molecular determinants of glioma cell migration and invasion. J Neurosurg 2001;94:978-984. (Pubitemid 32799599)
24. Yoshizaki T, Sato H, Furukawa M: Recent advances in the regulation of matrix metalloproteinase 2 activation from basic research to clinical implication (Review). Oncol Rep 2002;9:607-611.
25. Arnold SM, Young AB, Munn RK, et al.: Expression of p53, bcl- 2, E-cadherin, matrixmetalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis. Clin Cancer Res 1999;5:4028-4033. (Pubitemid 30013780)
26. Brayton J, Qing Z, Hart MN, et al.: Influence of adhesion molecule expression by human brain microvessel endothelium on cancer cell adhesion. J Neuroimmunol 1998;14:104-112. (Pubitemid 28389582)
27. Puerschel WC, Gawaz M, Worret WI, et al.: Immunoreactivity of glycoprotein IIb is present in metastasized but not in non-metastasized primary malignant melanoma. Br J Dermatol 1996;135:883-887. (Pubitemid 26397915)
28. Goldbrunner RH, Bernstein JJ, Tonn JC: Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir (Wien) 1999;141:295-305. (Pubitemid 29137544)
29. Weber GF, Ashkar S: Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers. Brain Res 2000;53:421-424. (Pubitemid 32000819)